Table 1.

Main characteristics and results of eligible studies

Author	Year	Country	OS		PFS		Overall response rate	Disease control rate
			Univariate analysis	Multivariate analysis	Univariate analysis	Multivariate analysis
Chen et al[21]	2005	China	S	S	N/A	N/A	N/A	N/A
Chan et al[20]	2009	China	S	S	N/A	N/A	P	P
Riaz et al[27]	2009	United States	S	S	N/A	N/A	P	P
Vora et al[29]	2009	United States	N/A	NS	N/A	NS	P	P
Shao et al[28]	2010	China	N/A	S	N/A	S	P	P
Kim et al[23]	2011	South Korea	S	S	S	S	P	P
Yau et al[30]	2011	China	S	S	S	S	N/A	N/A
Kao et al[22]	2012	China	N/A	S	N/A	N/A	N/A	N/A
Lee et al[24]	2012/H	South Korea	S	S	S	NS	P	P
Lee et al[24]	2012/C	South Korea	S	S	S	NS	P	P
Memon et al[25]	2012	United States	S	S	N/A	N/A	C	N/A
Personeni et al[26]	2012	Italy	N/A	S	N/A	N/A	N/A	N/A

2012/H: Hepatic arterial infusional chemotherapy study; 2012/C: Concurrent chemoradiation therapy study; S: Significant relationship between α-fetoprotein (AFP) response and survival; NS: No significant relationship between AFP response and survival; N/A: Not available or not applicable; P: Directly provided by the article; C: Need to be calculated by the data provided by the article; OS: Overall survival; PFS: Progression-free survival.